Manage Tickers

Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current
Analyst Rating Guide

News

Back

ADMA Biologics Q2 Adj. EPS $0.14, Inline, Sales $121.98M Miss $122.67M Estimate

Author: Benzinga Newsdesk | August 06, 2025 04:07pm
ADMA Biologics (NASDAQ:ADMA) reported quarterly earnings of $0.14 per share which met the analyst consensus estimate. This is a 7.69 percent increase over earnings of $0.13 per share from the same period last year. The company reported quarterly sales of $121.98 million which missed the analyst consensus estimate of $122.67 million by 0.56 percent. This is a 13.80 percent increase over sales of $107.19 million the same period last year.

Posted In: ADMA


CORE & Plaid

CORE Finalist

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist